Literature DB >> 11840567

Cluster analysis of an extensive human breast cancer cell line protein expression map database.

Robert A Harris1, Alice Yang, Robert C Stein, Kevan Lucy, Luc Brusten, Athula Herath, Raj Parekh, Michael D Waterfield, Michael J O'Hare, Munro A Neville, Martin J Page, Marketa J Zvelebil.   

Abstract

In the current study, the protein expression maps (PEMs) of 26 breast cancer cell lines and three cell lines derived from normal breast or benign disease tissue were visualised by high resolution two-dimensional gel electrophoresis. Analysis of this data was performed with ChiClust and ChiMap, two analytical bioinformatics tools that are described here. These tools are designed to facilitate recognition of specific patterns shared by two or more (a series) PEMs. Both tools use PEMs that were matched by an image analysis program and locally written programs to create a match table that is saved in an object relational database. The ChiClust tool uses clustering and subclustering methods to extract statistically significant protein expression patterns from a large series of PEMs. The ChiMap tool calculates a differential value (either as percentage change or a fold change) and represents these graphically. All such differentials or just those identified using ChiClust can be submitted to ChiMap. These methods are not dependent on any particular commercial image analysis program, and the whole software package gives an integrated procedure for the comparison and analysis of a series of PEMs. The ChiClust tool was used here to order the breast cell lines into groups according to biological characteristics including morphology in vitro and tumour forming ability in vivo. ChiMap was then used to highlight eight major protein feature-changes detected between breast cancer cell lines that either do or do not proliferate in nude mice. Mass spectrometry was used to identify the proteins. The possible role of these proteins in cancer is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840567     DOI: 10.1002/1615-9861(200202)2:2<212::aid-prot212>3.0.co;2-h

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  12 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 2.  The application of 2D gel-based proteomics methods to the study of breast cancer.

Authors:  Robert C Stein; Marketa J Zvelebil
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 3.  Proteomic dissection of dome formation in a mammary cell line.

Authors:  I Zucchi; R Dulbecco
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

4.  Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth.

Authors:  I Azoulay-Alfaguter; R Elya; L Avrahami; A Katz; H Eldar-Finkelman
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

5.  Functional proteomic analysis of long-term growth factor stimulation and receptor tyrosine kinase coactivation in Swiss 3T3 fibroblasts.

Authors:  Kohji Nagano; Akunna Akpan; Gayathri Warnasuriya; Steven Corless; Nick Totty; Alice Yang; Robert Stein; Marketa Zvelebil; Allan Stensballe; Al Burlingame; Michael Waterfield; Rainer Cramer; John F Timms; Søren Naaby-Hansen
Journal:  Mol Cell Proteomics       Date:  2012-09-06       Impact factor: 5.911

6.  The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing = different lists of significant proteins.

Authors:  Sreelatha Meleth; Jessy Deshane; Helen Kim
Journal:  BMC Biotechnol       Date:  2005-02-11       Impact factor: 2.563

7.  Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer.

Authors:  Edward R Sauter; W Zhu; X-J Fan; R P Wassell; I Chervoneva; G C Du Bois
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

8.  Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

Authors:  Charles F Streckfus; Daniel Arreola; Cynthia Edwards; Lenora Bigler
Journal:  J Oncol       Date:  2012-04-10       Impact factor: 4.375

9.  Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry.

Authors:  E Korsching; J Packeisen; M W Helms; C Kersting; R Voss; P J van Diest; B Brandt; E van der Wall; W Boecker; H Bürger
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

10.  Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues.

Authors:  M V Dwek; A A Alaiya
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.